KRAS and pancreatic adenocarcinoma: The graphical summary of the mutations showed that there were 139 K-ras nonsynonymous mutations in pancreatic adenocarcinoma samples, and 130 of them were G12C/D/R/S/V in the kinase domain (Fig 2).